Skip to content
PubMed This is a summary of 83 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 83 referenced papers

Top Authors

Albert J. Czaja
Mayo Clinic
Christoph Schramm
Universität Hamburg
Ansgar W. Lohse
Johannes Gutenberg University Mainz
Giorgina Mieli‐Vergani
King's College Hospital
Diego Vergani
University College London
Xiong Ma
State Key Laboratory of Oncogene and Related Genes
Gideon M. Hirschfield
Toronto General Hospital
Michael A. Heneghan
King's College Hospital NHS Foundation Trust
Nikolaos Gatselis
University Hospital of Larissa
Cumali Efe
Harran University

Top Institutions

Ranked by publications Top 10 institutions
03

Shanghai Jiao Tong University

Shanghai, China

52 papers

References

References (83)
  1. 1

    The importance of autoantibody detection in autoimmune hepatitis.

    Cancado EL, Abrantes-Lemos CP, Terrabuio DR

    Frontiers in immunology 2015; (6()):222 doi:10.3389/fimmu.2015.00222.

    PMID: 26029208
  2. 2

    Prognostic Implications of Antibodies to Soluble Liver Antigen in Autoimmune Hepatitis: A PRISMA-Compliant Meta-Analysis.

    Chen ZX, Shao JG, Shen Y, et al.

    Medicine 2015; (94(23)):e953 doi:10.1097/MD.0000000000000953.

    PMID: 26061326
  3. 3

    Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes.

    Park Y, Cho Y, Cho EJ, Kim YJ

    Clinical and molecular hepatology 2015; (21(2)):150-7 doi:10.3350/cmh.2015.21.2.150.

    PMID: 26157752
  4. 4

    Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.

    Lin R, Zhou L, Zhang J, Wang B

    International journal of clinical and experimental pathology 2015; (8(5)):5153-60.

    PMID: 26191211
  5. 5

    EASL Clinical Practice Guidelines: Autoimmune hepatitis.

    Journal of hepatology 2015; (63(4)):971-1004.

    PMID: 26341719
  6. 6

    Autoimmune hepatitis in India: single tertiary referral centre experience.

    Amarapurkar D, Dharod M, Amarapurkar A

    Tropical gastroenterology : official journal of the Digestive Diseases Foundation 2015; (36(1)):36-45 doi:10.7869/tg.243.

    PMID: 26591953
  7. 7

    The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis.

    An Haack I, Derkow K, Riehn M, et al.

    PloS one 2015; (10(11)):e0143715 doi:10.1371/journal.pone.0143715.

    PMID: 26599014
  8. 8

    The clinical phenotypes of autoimmune hepatitis: A comprehensive review.

    Wang Q, Yang F, Miao Q, et al.

    Journal of autoimmunity 2016; (66()):98-107.

    PMID: 26614611
  9. 9

    [Clinical analysis of liver transplantation for autoimmune hepatitis].

    Zhou SN, Zhang N, Su HB, et al.

    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2015; (23(11)):860-4.

    PMID: 26743248
  10. 10

    Seronegative autoimmune hepatitis in children: Spectrum of disorders.

    Maggiore G, Socie G, Sciveres M, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2016; (48(7)):785-91.

    PMID: 27079745
  11. 11

    Production of Proinflammatory Cytokines by Monocytes in Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells.

    Arterbery AS, Osafo-Addo A, Avitzur Y, et al.

    Journal of immunology (Baltimore, Md. : 1950) 2016; (196(10)):4040-51 doi:10.4049/jimmunol.1502276.

    PMID: 27183637
  12. 12

    The utility of repeat liver biopsy in autoimmune hepatitis: a series of 20 consecutive cases.

    Putra J, Toor A, Suriawinata AA

    Pathology 2016; (48(5)):449-53.

    PMID: 27306577
  13. 13

    Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes.

    Wong GW, Yeong T, Lawrence D, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2017; (37(3)):449-457 doi:10.1111/liv.13236.

    PMID: 27541063
  14. 14

    Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria.

    Balitzer D, Shafizadeh N, Peters MG, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017; (30(5)):773-783 doi:10.1038/modpathol.2016.267.

    PMID: 28106105
  15. 15

    Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients.

    Nguyen Canh H, Harada K, Ouchi H, et al.

    Journal of clinical pathology 2017; (70(11)):961-969 doi:10.1136/jclinpath-2016-204271.

    PMID: 28428284
  16. 16

    Autoimmune-like chronic hepatitis induced by olmesartan.

    Barge S, Ziol M, Nault JC

    Hepatology (Baltimore, Md.) 2017; (66(6)):2086-2088 doi:10.1002/hep.29228.

    PMID: 28437842
  17. 17

    Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis.

    Efe C, Hagström H, Ytting H, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017; (15(12)):1950-1956.e1 doi:10.1016/j.cgh.2017.06.001.

    PMID: 28603052
  18. 18

    Seronegative Autoimmune Hepatitis A Clinically Challenging Difficult Diagnosis.

    Sherigar JM, Yavgeniy A, Guss D, et al.

    Case reports in medicine 2017; (2017()):3516234 doi:10.1155/2017/3516234.

    PMID: 28761444
  19. 19

    Histological Changes in Autoimmune Hepatitis with Graves' Disease: A Child Case Report.

    Yamada M, Shibata H, Masugi Y, et al.

    Internal medicine (Tokyo, Japan) 2017; (56(16)):2139-2143 doi:10.2169/internalmedicine.8417-16.

    PMID: 28781316
  20. 20

    Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.

    Roberts SK, Lim R, Strasser S, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2018; (16(2)):268-277 doi:10.1016/j.cgh.2017.09.063.

    PMID: 29050991
  21. 21

    Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients.

    Guo L, Zheng L, Hu L, et al.

    Medical science monitor : international medical journal of experimental and clinical research 2017; (23()):5106-5112 doi:10.12659/msm.907300.

    PMID: 29073121
  22. 22

    Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis.

    Hartl J, Ehlken H, Sebode M, et al.

    Journal of hepatology 2018; (68(4)):754-763 doi:10.1016/j.jhep.2017.11.020.

    PMID: 29180000
  23. 23

    Suitability of the simplified autoimmune hepatitis score for the diagnosis of autoimmune hepatitis in a German cohort.

    Wobser H, Paur T, Schnoy E, et al.

    United European gastroenterology journal 2018; (6(2)):247-254 doi:10.1177/2050640617711632.

    PMID: 29511554
  24. 24

    Autoimmune hepatitis in 828 Brazilian children and adolescents: clinical and laboratory findings, histological profile, treatments, and outcomes.

    Porta G, Carvalho E, Santos JL, et al.

    Jornal de pediatria 2019; (95(4)):419-427 doi:10.1016/j.jped.2018.04.007.

    PMID: 29856944
  25. 25

    Autoimmune Hepatitis in the East and the West.

    Ngu JH, Gearry RB, Stedman CAM

    Inflammatory intestinal diseases 2017; (1(4)):147-149 doi:10.1159/000455177.

    PMID: 29922670
  26. 26

    Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.

    Martínez Casas OY, Díaz Ramírez GS, Marín Zuluaga JI, et al.

    Gastroenterologia y hepatologia 2018; (41(9)):544-552 doi:10.1016/j.gastrohep.2018.05.019.

    PMID: 30017212
  27. 27

    The Imbalance between Foxp3+Tregs and Th1/Th17/Th22 Cells in Patients with Newly Diagnosed Autoimmune Hepatitis.

    Liang M, Liwen Z, Yun Z, et al.

    Journal of immunology research 2018; (2018()):3753081 doi:10.1155/2018/3753081.

    PMID: 30050955
  28. 28

    Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

    van den Brand FF, van Nieuwkerk CMJ, Verwer BJ, et al.

    Alimentary pharmacology & therapeutics 2018; (48(7)):761-767 doi:10.1111/apt.14939.

    PMID: 30109891
  29. 29

    Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom.

    Dyson JK, Wong LL, Bigirumurame T, et al.

    Alimentary pharmacology & therapeutics 2018; (48(9)):951-960 doi:10.1111/apt.14968.

    PMID: 30226274
  30. 30

    Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.

    Kerkar N, Chan A

    Clinics in liver disease 2018; (22(4)):689-702 doi:10.1016/j.cld.2018.06.005.

    PMID: 30266157
  31. 31

    Clinical presentation of autoimmune hepatitis in Pakistani children.

    Somroo GB, Rai AA, Luck NH, Abbas Z

    The Pan African medical journal 2018; (30()):117 doi:10.11604/pamj.2018.30.117.12692.

    PMID: 30364457
  32. 32

    Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine.

    Giannakopoulos G, Verbaan H, Friis-Liby IL, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019; (51(2)):253-257 doi:10.1016/j.dld.2018.10.004.

    PMID: 30389427
  33. 33

    Well-controlled autoimmune hepatitis treatment withdrawal may be safely accomplished without liver-biopsy guidance.

    Guirguis J, Alonso Y, Lopez R, Carey W

    Gastroenterology report 2018; (6(4)):284-290 doi:10.1093/gastro/goy020.

    PMID: 30430017
  34. 34

    Differential characteristics in drug-induced autoimmune hepatitis.

    Martínez-Casas OY, Díaz-Ramírez GS, Marín-Zuluaga JI, et al.

    JGH open : an open access journal of gastroenterology and hepatology 2018; (2(3)):97-104 doi:10.1002/jgh3.12054.

    PMID: 30483571
  35. 35

    Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)?

    Harrison L, Gleeson D

    Liver international : official journal of the International Association for the Study of the Liver 2019; (39(4)):610-620 doi:10.1111/liv.14051.

    PMID: 30667576
  36. 36

    Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis.

    Santiago P, Schwartz I, Tamariz L, Levy C

    Alimentary pharmacology & therapeutics 2019; (49(7)):830-839 doi:10.1111/apt.15157.

    PMID: 30761563
  37. 37

    Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country.

    Choi J, Choi GH, Lee D, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2019; (39(5)):985-994 doi:10.1111/liv.14082.

    PMID: 30821090
  38. 38

    Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: A nationwide register-based cohort study in Finland.

    Puustinen L, Barner-Rasmussen N, Pukkala E, Färkkilä M

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2019; (51(9)):1294-1299 doi:10.1016/j.dld.2019.01.015.

    PMID: 30850346
  39. 39

    Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.

    Yu ZJ, Zhang LL, Huang TT, et al.

    European journal of gastroenterology & hepatology 2019; (31(7)):873-877 doi:10.1097/MEG.0000000000001367.

    PMID: 31150366
  40. 40

    Genetic and Environmental Risk Factors for Autoimmune Hepatitis.

    Lammert C

    Clinical liver disease 2019; (14(1)):29-32 doi:10.1002/cld.798.

    PMID: 31391934
  41. 41

    Longterm Survival After Liver Transplantation for Autoimmune Hepatitis: Results From the European Liver Transplant Registry.

    Heinemann M, Adam R, Berenguer M, et al.

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2020; (26(7)):866-877 doi:10.1002/lt.25739.

    PMID: 32112516
  42. 42

    Statin-induced autoimmune hepatitis in patients with type 1 diabetes: A report of two cases and literature review.

    Kawasaki E, Fukuyama T, Kuriyama E, et al.

    Journal of diabetes investigation 2020; (11(6)):1673-1676 doi:10.1111/jdi.13271.

    PMID: 32277861
  43. 43

    A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.

    Liwinski T, Casar C, Ruehlemann MC, et al.

    Alimentary pharmacology & therapeutics 2020; (51(12)):1417-1428 doi:10.1111/apt.15754.

    PMID: 32383181
  44. 44

    High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation.

    Pape S, Gevers TJG, Vrolijk JM, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2020; (40(9)):2164-2171 doi:10.1111/liv.14513.

    PMID: 32410363
  45. 45

    Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis.

    Gerussi A, Halliday N, Saffioti F, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2020; (52(7)):761-767 doi:10.1016/j.dld.2020.04.012.

    PMID: 32473882
  46. 46

    Long-Term Observation of Cyclosporine as Second-Line Therapy in Adults for Severe Acute Autoimmune Hepatitis.

    Noguchi F, Chu PS, Taniki N, et al.

    Hepatology (Baltimore, Md.) 2021; (73(6)):2594-2597 doi:10.1002/hep.31597.

    PMID: 33068296
  47. 47

    Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver.

    Preti M, Schlott L, Lübbering D, et al.

    JCI insight 2021; (6(6)).

    PMID: 33600378
  48. 48

    Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves Disease.

    Patel AM, Stanback C, Vellanki P

    AACE clinical case reports 2021; (7(1)):36-39 doi:10.1016/j.aace.2020.11.007.

    PMID: 33851017
  49. 49

    Letter to the editor: Both simplified and revised IAIHG scores should be considered in diagnosing acute autoimmune hepatitis.

    Shen Y, Xue M, Yang L

    Liver international : official journal of the International Association for the Study of the Liver 2021; (41(8)):1973-1975 doi:10.1111/liv.14946.

    PMID: 33988911
  50. 50

    Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis.

    Biewenga M, Verhelst X, Baven-Pronk M, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(8)):1776-1783.e4 doi:10.1016/j.cgh.2021.05.024.

    PMID: 34022454
  51. 51

    A reasoned approach to the treatment of autoimmune hepatitis.

    Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2021; (53(11)):1381-1393 doi:10.1016/j.dld.2021.05.033.

    PMID: 34162505
  52. 52

    Seronegative autoimmune hepatitis in children: a single-center experience.

    Islek A, Keskin H

    Acta gastro-enterologica Belgica 2021; (84(2)):305-310 doi:10.51821/84.2.305.

    PMID: 34217180
  53. 53

    Autoimmune hepatitis in Egyptian children: A single center experience.

    Mogahed E, El-Karaksy H, Zaki H, Abdullatif H

    International journal of immunopathology and pharmacology 2022; (36()):20587384211073265 doi:10.1177/20587384211073265.

    PMID: 35231187
  54. 54

    A Case Report of Sjögren's Syndrome Presenting With Autoimmune Hepatitis.

    Caretti R, Wojtas C, Baniasadi M, et al.

    Cureus 2022; (14(3)):e23464 doi:10.7759/cureus.23464.

    PMID: 35494911
  55. 55

    Drug-induced autoimmune hepatitis: A minireview.

    Tan CK, Ho D, Wang LM, Kumar R

    World journal of gastroenterology 2022; (28(24)):2654-2666 doi:10.3748/wjg.v28.i24.2654.

    PMID: 35979160
  56. 56

    Autoimmune post-infantile giant cell hepatitis: a case report and review of the literature.

    Xiao Y, Gao ZH, Deschenes M

    Canadian liver journal 2021; (4(2)):104-109 doi:10.3138/canlivj-2020-0024.

    PMID: 35991767
  57. 57

    Autoimmune serology testing in clinical practice: An updated roadmap for the diagnosis of autoimmune hepatitis.

    Dalekos GN, Gatselis NK

    European journal of internal medicine 2023; (108()):9-17 doi:10.1016/j.ejim.2022.11.013.

    PMID: 36400668
  58. 58

    Hepatocellular Carcinoma in Patients With Liver Cirrhosis Secondary to Autoimmune Hepatitis: A Case Series and Literature Review.

    Perera Mesa H, Lugo L, Altshuler E

    Cureus 2022; (14(10)):e30698 doi:10.7759/cureus.30698.

    PMID: 36439579
  59. 59

    Seronegative Autoimmune Hepatitis.

    Bhumi SA, Wu GY

    Journal of clinical and translational hepatology 2023; (11(2)):459-465 doi:10.14218/JCTH.2022.00235.

    PMID: 36643052
  60. 60

    Applicability of International Autoimmune Hepatitis Group (IAIHG) Scoring System for Autoimmune Hepatitis in Pediatrics.

    Sakulsaengprapha V, Wasuwanich P, Naraparaju G, et al.

    Biology 2023; (12(3)) doi:10.3390/biology12030479.

    PMID: 36979170
  61. 61

    Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis.

    Czaja AJ

    Digestive diseases and sciences 2023; (68(7)):2824-2842 doi:10.1007/s10620-023-07967-5.

    PMID: 37160542
  62. 62

    Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis-The 20-Year Experience of a High-Volume Tertiary Center.

    Buechter M, Dorn D, Möhlendick B, et al.

    Journal of clinical medicine 2023; (12(13)) doi:10.3390/jcm12134192.

    PMID: 37445225
  63. 63

    Estimating autoimmune hepatitis in patients with hepatic dysfunction.

    Khetan R, Sharma J, Mittal A, et al.

    Indian journal of medical microbiology 2023; (45()):100411 doi:10.1016/j.ijmmb.2023.100411.

    PMID: 37573048
  64. 64

    Development and validation of a noninvasive prediction model of autoimmune hepatitis in patients with liver diseases.

    Wang L, Hu YF, Yang AY, et al.

    Scandinavian journal of gastroenterology 2024; (59(1)):62-69 doi:10.1080/00365521.2023.2249571.

    PMID: 37649307
  65. 65

    Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1.

    Li Y, Zhou L, Huang Z, et al.

    JHEP reports : innovation in hepatology 2024; (6(1)):100926 doi:10.1016/j.jhepr.2023.100926.

    PMID: 38089552
  66. 66

    Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood.

    Warner S, Rajanayagam J, Russell E, et al.

    JHEP reports : innovation in hepatology 2024; (6(2)):100901 doi:10.1016/j.jhepr.2023.100901.

    PMID: 38235169
  67. 67

    Retrospective, single-center analysis of autoimmune hepatitis in Jordanian children: clinical features, treatments, and outcomes.

    Altamimi E, Al Omari D, Obeidat H, Barham K

    BMC pediatrics 2024; (24(1)):102 doi:10.1186/s12887-024-04590-9.

    PMID: 38331749
  68. 68

    [Drug-induced autoimmune-like liver injury].

    Weber S

    Innere Medizin (Heidelberg, Germany) 2024; (65(4)):334-339 doi:10.1007/s00108-024-01669-4.

    PMID: 38374310
  69. 69

    [Treatment of autoimmune hepatitis-First-line, second-line and third-line treatment].

    Taubert R, Engel B

    Innere Medizin (Heidelberg, Germany) 2024; (65(4)):325-333 doi:10.1007/s00108-024-01679-2.

    PMID: 38456902
  70. 70

    Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study.

    Plagiannakos CG, Hirschfield GM, Lytvyak E, et al.

    Journal of hepatology 2024; (81(2)):227-237 doi:10.1016/j.jhep.2024.03.021.

    PMID: 38527524
  71. 71

    Worse fibro-inflammatory activity on diagnostic liver biopsy adversely impacts biochemical remission in autoimmune hepatitis.

    Khonde P, Choudhury S, Spies NC, et al.

    Clinics and research in hepatology and gastroenterology 2024; (48(8)):102442 doi:10.1016/j.clinre.2024.102442.

    PMID: 39103121
  72. 72

    Hellenic Association for the Study of the Liver (HASL): revised clinical practice guidelines for autoimmune hepatitis.

    Dalekos GN, Papatheodoridis GV, Koskinas J, et al.

    Annals of gastroenterology 2024; (37(6)):623-654 doi:10.20524/aog.2024.0924.

    PMID: 39568707
  73. 73

    Liver Transplantation for Autoimmune Hepatitis: 20 Years of Tertiary Centre Experience.

    Sağlam O, Harputluoğlu MMM, Bilgiç Y, et al.

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2024; (36(3)):145-151 doi:10.5152/tjg.2024.24464.

    PMID: 39696995
  74. 74

    Rheumatological diseases in patients with autoimmune hepatitis in a fourth level hospital in Bogotá between 2013 and 2023.

    Almánzar Cortés JS, Vergara Cabra C, Uchima-Vera MP, et al.

    Reumatologia clinica 2025; (21(2)):501812 doi:10.1016/j.reumae.2025.501812.

    PMID: 40000291
  75. 75

    Clinical outcomes in patients with autoimmune hepatitis and primary biliary cholangitis overlap syndrome in the United States.

    Goyal RM, Bansal B, Ayyad M, et al.

    Clinics and research in hepatology and gastroenterology 2025; (49(6)):102598 doi:10.1016/j.clinre.2025.102598.

    PMID: 40294647
  76. 76

    EASL Clinical Practice Guidelines on the management of autoimmune hepatitis.

    Journal of hepatology 2025; (83(2)):453-501 doi:10.1016/j.jhep.2025.03.017.

    PMID: 40348684
  77. 77

    Fulminant Primary Biliary Cholangitis-Autoimmune Hepatitis (PBC-AIH) Overlap Syndrome in a 27-Year-Old Woman With Childhood-Onset AIH: Steroid-Refractory Decompensation Necessitating Urgent Transplant Evaluation.

    Said E, Tafesse Y, Elbenawi HR, et al.

    Cureus 2025; (17(7)):e87519 doi:10.7759/cureus.87519.

    PMID: 40786261
  78. 78

    The prevalence of autoimmune hepatitis is rising: Estimates and trends from a large, multi-ethnic cohort in the United States.

    Yao J, Jiang SF, Kapoor C, et al.

    Hepatology communications 2025; (9(11)) doi:10.1097/HC9.0000000000000824.

    PMID: 41056496
  79. 79

    Comparative Effectiveness of Mycophenolate Mofetil and Tacrolimus as a Second-Line Therapy for Autoimmune Hepatitis: A Systematic Review and Meta-Analysis.

    Almalki F, Alarmati ST, Shata RN, et al.

    Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2025; 1-17 doi:10.1159/000548894.

    PMID: 41078044
  80. 80

    Autoimmune Hepatitis Associated with Other Autoimmune Diseases: A Critical Review.

    Zhao D, Wu GY

    Journal of clinical and translational hepatology 2025; (13(10)):869-877 doi:10.14218/JCTH.2025.00153.

    PMID: 41089714
  81. 81

    Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study.

    Corpechot C, Hornus P, Cals M, et al.

    JHEP reports : innovation in hepatology 2025; (7(11)):101546 doi:10.1016/j.jhepr.2025.101546.

    PMID: 41098237
  82. 82

    Triple autoimmune overlap syndrome of the liver: a rare case of concomitant PBC, PSC, and AIH.

    Hassen H, Dahmani W, Bedoui G, et al.

    Future science OA 2025; (11(1)):2601633 doi:10.1080/20565623.2025.2601633.

    PMID: 41355485
  83. 83

    Extrahepatic Autoimmune Diseases in Autoimmune Hepatitis: Their Prevalence, Predictors, and Influence on Early Treatment Outcomes.

    Ma YY, Zhao WH, Ou KY, et al.

    Journal of clinical and translational hepatology 2026; (14(1)):23-30 doi:10.14218/JCTH.2025.00424.

    PMID: 41659999